The answer first, then why
What are people asking about retatrutide?
Is retatrutide FDA approved now?
No. Retatrutide wasn't FDA-approved by mid-2026. Phase 3, the last large study round, was still being run by Eli Lilly. A 2024 medical article called it the first obesity drug of its kind. The article also said testing wasn't done [14]. The maker must finish Phase 3, send a full request, and pass FDA review. Those steps hadn't happened, so you couldn't get an approved prescription. Your doctor couldn't write you one either.
When will retatrutide reach pharmacies?
No date is set. Phase 3 studies were still under way in mid-2026 [7][8]. The Phase 3 weight-loss study called TRIUMPH-1 is part of that work. After the studies end, Eli Lilly has to ask the FDA for approval. FDA staff then compare the help with the harm. A faster review is possible, but it doesn't promise approval. The date depends on results and choices that haven't happened. The retatrutide availability page shows what you're waiting for.
Can a doctor give you approved retatrutide?
No approved drug is available, so you can receive retatrutide only if a study accepts you, checks your health, gives the drug at no cost, and watches for harm. Powder sold elsewhere with "for research only" on the label isn't the same. No drug agency checks its name, strength, or cleanliness. An online vial also comes without the care that study staff provide.
Can anyone legally sell retatrutide as medicine?
No approved sale is allowed in the United States or most other places. Retatrutide isn't on the federal controlled-drug list. That only means it isn't handled like drugs with strict limits on who may have them. Selling it as medicine without FDA approval still breaks federal drug law. During 2025, more than fifty sellers got FDA warnings. Local rules on having it may differ. None of that makes your vial an approved drug.
Who makes retatrutide for the studies?
Retatrutide was developed by Eli Lilly and Company. Eli Lilly runs the Phase 3 studies and holds the right to test the drug. The company lists retatrutide as a possible future medicine for obesity and diabetes. No other company has approved rights to make or sell it. In fact, no company can sell you approved retatrutide yet.
Is retatrutide approved in another country?
No. Retatrutide wasn't approved in any country by mid-2026. Eli Lilly runs studies in several countries, but a study site doesn't mean sales are approved. After good Phase 3 results, the company must ask each country on its own. The European Medicines Agency, Health Canada, and other large drug agencies hadn't approved retatrutide. A nearby study doesn't prove sales are legal.
Where does retatrutide stand in the US?
It's still being tested. Retatrutide is in Phase 3 studies and hasn't been sent to the FDA for approval. In 2025, a review looked at Phase 1/2, meaning the early safety and middle test results. The writers called weight loss of up to about 24 percent a large gain over older drugs, but said retatrutide still wasn't approved [6]. A faster FDA review may be possible later. For you, there's no approval now.
Can you get a prescription for retatrutide?
No legal prescription route exists yet. A doctor can't prescribe retatrutide for care because it isn't approved. People in studies don't get a normal prescription. They join a study and get the drug from its staff. A business claiming it can prescribe retatrutide isn't using an approved route. A prescription label can't turn an unapproved vial into an approved drug.
Can you get retatrutide in the USA?
Only through a study. The TRIUMPH-1 page on ClinicalTrials.gov, the federal study-listing website, shows several US sites that may accept people [7]. Outside a study, no pharmacy, online clinic, or doctor in the United States can give you approved retatrutide. Powder marked "for research only" differs from drug made for a real study. You can't know whether an online vial has the right drug or is clean enough for a shot.
What did retatrutide do to weight in studies?
It led to a large average loss in one study. Retatrutide copies three hormones. One may quiet hunger. Another helps insulin clear sugar after food. The third may raise energy use and cut liver fat. A 2025 review said this mix might be part of the large early weight change [6]. In a 48-week Phase 2 obesity study, the 12 mg group lost 24.2 percent on average [1]. That average can't tell you what your scale will show.
What does retatrutide do after a shot?
The medicine takes on three hormone jobs. The first may quiet hunger. It can also help insulin work after food. The second adds help with insulin and fat use. The third copies glucagon. That hormone makes your liver release sugar and may raise energy use. In a 48-week Phase 2 obesity study, the 12 mg group lost 24.2 percent on average. People on placebo lost 2.1 percent [1]. Close-up pictures showed retatrutide at the cell spots used by all three hormones [3]. Your result may differ greatly.
How to reconstitute retatrutide from online powder?
No mixing method has approval. Reconstitute means adding liquid to powder for a shot. Eli Lilly gave study sites retatrutide already mixed as a liquid [1][4]. The studies didn't use online powder. You can't confirm that powder's name, strength, or lack of germs. Mixing steps wouldn't fix those risks. We don't give steps for making an unapproved shot. Such steps could look far safer than they are.
Who gives retatrutide during a study?
Each week, study staff gave retatrutide under the skin [1][2][4]. They chose the amount, gave or watched the shot, and checked each person's health. Outside a study, there are no approved directions and no known clean supply. We tell you what study staff did, not how to inject online powder. Without a study, you'd lack both a proven drug and trained care.
When did weight start to change with retatrutide?
The first gap in weight appeared within four to eight weeks at higher amounts. A 2025 review found that in the Phase 1/2 results [6]. With weekly shots, the drug reached a fairly steady level in three to four weeks. Its roughly 6-day half-life means half takes about that long to leave the blood [4]. In Phase 2, weight continued to fall throughout the 48-week study at the highest amount. Another Phase 2 finding was that the drop hadn't clearly leveled off by week 48 [1]. Your weight might change on a different clock.
Is retatrutide better than tirzepatide for weight?
We don't know. A Phase 3 study is comparing both drugs, but it hasn't reported results [10]. In separate Phase 2 studies, retatrutide reached 24.2 percent weight loss at 48 weeks. Tirzepatide reached about 15–21 percent. You can't make a fair choice from those numbers. The studies used different people, amounts, and timing. Only the direct study can answer the question. Until it reports, you can't know which drug fits your health.
What weekly retatrutide amounts did studies test?
In the Phase 2 obesity study, doctors tested weekly shots of 1, 4, 8, and 12 mg [1]. In the Phase 2 study of type 2 diabetes, doctors moved from 0.5 mg toward no more than 12 mg a week, one step at a time [2]. Those are study facts, not directions for you. Retatrutide isn't approved, so no weekly amount is approved for your use.
Can you safely mix retatrutide powder with water?
The studies don't answer that. They used retatrutide already mixed as a liquid, not dried powder or special water meant to slow germs [1][4]. Online sellers often offer dried powder. You can't prove that powder is retatrutide, has the stated strength, or is free of germs. Adding water can't fix dirt or a false label. We don't give mixing steps for a shot that hasn't been approved or checked.
Can you switch from tirzepatide to retatrutide?
No published study gives switching steps. One study compares both drugs, but doesn't test people changing between them [10]. Tirzepatide is approved. Retatrutide isn't. A doctor would need to watch any change involving a test drug. That choice belongs in a study or another place with medical care. Missing facts can't become safe steps for you.
Why is the GLP-3 nickname for retatrutide wrong?
The GLP-3 nickname is wrong. People use GLP-3 because retatrutide copies three hormone jobs, but the name isn't sound. The lab term GLP-3 names a small protein piece, not a working hormone with a proven drug job. Retatrutide copies hormones called GIP, GLP-1, and glucagon. GLP-1 helps curb hunger and manage sugar after food. A related hormone called GLP-2 mostly works in the gut. Those names don't make retatrutide a GLP-3 drug [1][3].
Which health problems are retatrutide studies checking?
Studies have tested retatrutide for obesity without type 2 diabetes [1] and with type 2 diabetes [2]. Other work includes people with fatty liver [5] or heart disease [8]. Researchers are also checking heart and kidney harm [9] and comparing retatrutide with tirzepatide [10]. Retatrutide isn't approved for any use. A 2025 review said obesity is the main aim, with possible help for other health problems [6].
Which three hormone jobs does retatrutide copy?
The first job copies GLP-1, the hormone that may curb hunger. GLP-1 also helps insulin handle blood sugar after food. The third job copies glucagon, which asks your liver to send sugar into the blood and may raise energy use. In 2024, close-up pictures showed retatrutide at cell spots used by all three hormones [3]. In lab cells, it copied the after-food insulin job most strongly [3]. This lab finding can't predict the weight you'd lose.
How often did studies give retatrutide?
Every published study placed one shot under the skin each week [1][2][4]. The timing fits the drug's roughly 6-day half-life, meaning half takes about that long to leave your blood. The earliest safety test found that timing [4]. Phase 3 studies also use weekly shots [7]. These are study facts. Retatrutide isn't approved, so there is no approved schedule outside a study.